共 42 条
[1]
Angus DC(2013)Severe sepsis and septic shock N Engl J Med 369 840-51
[2]
van der Poll T(2013)Committee of Sepsis Registry 2007 JSICM Sepsis 1st Registry: Management of severe sepsis and septic shock in Japan J Jpn Soc Intensive Care Med 20 329-34
[3]
Masaoka T(2000)The efficacy of intravenous immunoglobulin in combination therapy with antibiotics for severe infections Jpn J Chemother 48 199-217
[4]
Hasegawa H(2016)Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study Thromb Haemost 115 1157-66
[5]
Takaku F(2003)2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Crit Care Med 31 1250-6
[6]
Hayakawa M(2015)Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study Clin Infect Dis 61 385-92
[7]
Yamakawa K(2015)Intravenous immunoglobulin use in septic shock patients after emergency laparotomy J Infect 71 158-66
[8]
Saito S(2017)Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016 Crit Care Med 45 486-552
[9]
Uchino S(2012)Bench-to-bedside review: immunoglobulin therapy for sepsis—biological plausibility from a critical care perspective Crit Care 16 206-6
[10]
Kudo D(2014)Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis? Eur J Intern Med 25 511-701